Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 9, 2017, after the close
10-Q filed May 9, 2017, 39 days after period end · 0001564590-17-009889
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $15.29M | $4.00K | $4.00K | $30.00K |
| Net Income | -$87.84M | -$49.76M | -$40.38M | -$17.83M |
| EPS Diluted | -$0.72 |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.45 |
| -$0.40 |
| -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
